RTI Biologics, Inc. (RTIX)
-NasdaqGS 4.30 
0.07(1.60%) 4:00PM EDT
| Prev Close: | 4.37 |
|---|
| Open: | 4.38 |
|---|
| Bid: | 4.01 x 100 |
|---|
| Ask: | 4.81 x 100 |
|---|
| 1y Target Est: | 5.08 |
|---|
| Beta: | 1.28 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 4.29 - 4.40 |
|---|
| 52wk Range: | 3.35 - 5.11 |
|---|
| Volume: | 152,799 |
|---|
| Avg Vol (3m): | 267,650 |
|---|
| Market Cap: | 240.83M |
|---|
| P/E (ttm): | 30.71 |
|---|
| EPS (ttm): | 0.14 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 5 Stocks Under $10 Set to Soarat TheStreet(Thu, May 16)
- RTI BIOLOGICS, INC. FinancialsEDGAR Online Financials(Fri, May 10)
- 3 Health Care Stocks Under $10 to Watchat TheStreet(Tue, May 7)
- RTI BIOLOGICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 3)
- RTI Biologics' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, Apr 25)
- RTI Biologics Earnings: Here’s Why Investors Like These Resultsat Wall St. Cheat Sheet(Thu, Apr 25)
- RTI Biologics Announces 2013 First Quarter ResultsBusiness Wire(Thu, Apr 25)
- Q1 2013 RTI Biologics, Inc. Earnings Release - Before Market OpenCCBN(Thu, Apr 25)
- RTI BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibEDGAR Online(Thu, Apr 25)
- RTI BIOLOGICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission oEDGAR Online(Wed, Apr 24)
- RTI Biologics Schedules 2013 First Quarter Earnings and Conference Call for April 25, 2013Business Wire(Thu, Apr 18)
- RTI Biologics Announces Positive Clinical Results for BioCleanse®-Processed BTB Allografts Used in ACL ReconstructionBusiness Wire(Wed, Mar 20)
- RTI Biologics® Receives 510(k) Clearance for Porcine Dermis ImplantBusiness Wire(Wed, Mar 13)
- RTI Biologics Launches New Line of Biologic Implants at Americas Hernia Society’s 15th Annual Hernia Repair Conference, March 13-16Business Wire(Tue, Mar 12)
- RTI Biologics Inc. Stock Downgraded (RTIX)at TheStreet(Tue, Mar 12)
Key Statistics
| Forward P/E (1 yr): | 17.20 |
|---|
| P/S (ttm): | 1.40 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.18 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.03 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.55 |
|---|
Business Summary
RTI Biologics, Inc., together with its subsidiaries, produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues.
View More